AG007QM8

117977-21-6 | 2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole

Chemical structure of 2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole, CAS 117977-21-6
AG007QM8
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 117977-21-6
Catalog Number AG007QM8(AGN-PC-07Y4VA)
Chemical Name 2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole
IUPAC Name 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole
InChI InChI=1S/C18H21N3O2S/c1-13-16(19-9-8-17(13)23-11-5-10-22-2)12-24-18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)
InChI Key BSXAHDOWMOSVAP-UHFFFAOYSA-N
MDL Number MFCD08063845
Molecular Formula C18H21N3O2S
Molecular Weight 343.4432
SMILES COCCCOC1=C(C(=NC=C1)CSC2=NC3=C([NH]2)C=CC=C3)C
UNII 304S7E320P
Synonyms
rabeprazole-thioether, 117977-21-6, 2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole, Rabeprazole Sulfide, 2-[[[4-(3-Methoxy Propoxy)-3-methyl pyridine-2-yl ]methyl ] thio]-1H-benzimidazole, UNII-304S7E320P, 2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole, 2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H-benzimidazole, 304S7E320P, AK-47315, 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]thio]benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-Benzimidazole, rabeprazole-thioether, W-200910, 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridyl]methylsulfanyl]-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methylpyridine-2-yl]methylthio]-1h-benzimidazole, 2-{[4(3-Methoxypropoxy)-3-methyl pyridine-2-yl]methylthio}-1H-benzimidazole, 2-{[4-(3-Methoxypropoxy)-3-methyl pyridine-2-yl]methylthio}-1H-benzimidazole, 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)thio)-, 1H-Benzimidazole,2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-, 2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfanyl)-1H-1,3-benzodiazole, Rabeprazole impurity E, 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylthio]-1H-benzimidazole, 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)THIO)-1H-BENZIMIDAZOLE, 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylthio)-1H-benzo[d]imidazole, 2-[{4-(3-methoxypropoxy)-3-methylpyridine-2-yl}methylthio]-1H-benzimidazole, 2-{[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylthio}-1H-benzimidazole, Rabeprazole impurity E [USP-MC], Desmethylrabeprazole thioether, CHEMBL51538, Rabeprazole Related CoMpound E, ACMC-1C867, SCHEMBL1306777, CTK4B0528, KS-00000IHF, DTXSID20433250, BSXAHDOWMOSVAP-UHFFFAOYSA-N, BCP12237, ANW-51933, MFCD08063845, ZINC21992166, AKOS015852518, CS-W003467, MCULE-8738411113, RTC-062482, 2-[[[4-(3-Methoxy Propoxy)-3-methyl pyridine-2-yl]methyl ] thio]-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole, AC-22626, AC-22627, ACM117977216, AJ-79752, AN-32972, BR-47315, CC-08455, CJ-17150, DS-14347, SY030473, AB0059977, AX8016917, TC-062482, 4CH-009310, FT-0642883, R0098, ST24028146, MFCD08063845 (95%), S-2351, 977M216, A803859, C-20418, I14-6092, 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylthio]-1H-benzimidazole, 2-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio]benzimidazole, 2-{[4(3-Methoxypropoxy)-3-methyl pyridine-2-yl]methylthio}-1Hbenzimidazole, 2-{4-(3-methoxypropoxy)-3-methylpyridine-2-yl}methylthio-1H-benzimidazole, 2-({[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfanyl)-1H-benzimidazole, 2-[[[3-methyl-4-(3-methoxypropoxy)-2-pyridinyl]methyl]thio]-1h-benzimidazol, 2-[[[4-(3-methoxy-propoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl thio]-1h-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methylsulfanyl]-1H-benzimidazole, 2-[{4-(3-methoxypropoxy)-3-methylpyridine-2-yl}-methylthio]-1H-benzimidazole, 2-[{4-(3-methoxypropoxy)-3-methylpyridine-2-yl}methylthio]-1H benzimidazole, 2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H -benzimidazole, 2-{[4-(3-methoxypropoxy)-3-methylpyridine-2-yl]methylthio}1h-benzo[d]imidazole, Rabeprazole thioether, Not Available, Rabeprazole sulphide, Rebeprazole sulfone N-oxide, ACN-039993, CID9949996, CS-O-08062, C523099, 924663-37-6, 2-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methyl]thio]-1H-benzimidazole, 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2-yl]methylsulfanyl]-1H-benzoimidazole, 1H-Benzimidazole, 2-[[[4-(3-methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl]methyl]sulfonyl]-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited